Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Colitis, Ulcerative 1

Interventions

peficitinib 1 golimumab 1 Vitamin E 1 NX-13 1 Methylprednisolone 1 Mesalamine 1 Iron-Dextran Complex 1 Infliximab 1 Andrographis paniculata extract 1 2-(3',4'-dihydroxyphenyl-1-azo)benzimidazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colitis, Ulcerative × Mesalamine × Lymphoid × Clear all

NCT02093663 2021-06-09

PACE

Takeda

Phase 3 Completed

107 enrolled 18 charts

Colitis, Ulcerative, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡